VERAPAMIL HYDROCHLORIDE

Product NDC: 50090-5253
11-digit product format: 500905253
Labeler code: 50090
Product ID: 50090-5253_caca7395-7eaa-4d05-bd4b-fb92e997f480
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: VERAPAMIL HYDROCHLORIDE
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA206173
Marketing category: ANDA
Marketing start: 2019-05-15
Substance: VERAPAMIL HYDROCHLORIDE
Active strength: 180 mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A206173-001	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05
A206173-002	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05
A206173-003	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A206173-001	AB
A206173-002	AB
A206173-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 105 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206173-002	VERAPAMIL HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206173-003	VERAPAMIL HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2022-11-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206173-001	VERAPAMIL HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-05	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 105 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206173-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206173-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206173-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206173-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206173-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206173-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206173-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206173-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206173-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206173-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206173-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206173-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206173-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206173-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206173-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206173-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206173-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206173-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206173-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206173-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206173-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206173-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206173-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206173-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206173-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206173-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206173-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206173-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206173-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206173-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206173-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206173-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206173-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206173-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206173-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206173-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206173-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206173-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206173-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206173-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: VERAPAMIL HYDROCHLORIDE
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
VERAPAMIL HYDROCHLORIDE	180 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
V3888OEY5R	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
897640	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5467dad4-f3ba-4036-b5f4-4d2d4d5abc34	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ea1f6fc8-bfc2-4421-a2eb-4e87c7c3e3c4	Product name	2	20230103
33ad674d-d105-6aa5-02fa-95ae4329b8cd	Product name	2	20180809
3279bd6d-5b02-e60b-3857-c853a2deb2dd	Product name	2	20170713
8ebb66e3-d7b3-f1e5-88aa-3369e64bb84a	Product name	1	20140508
940a1faa-2df8-cc65-be37-1b97984b4ea3	Product name	1	20140508
d3b67bc2-0e96-e3ec-06a9-90afcc07bf13	Product name	1	20140508
e2fcd66c-a043-3187-790d-b0342deb1149	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-5253-4	2023-02-07	C162847	48780-1	f386c64a-00c3-0266-e053-dadaa90a7c1a	VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP Extended Release Film Coated Tablets
50090-5253-4	2023-01-30	C162847	48780-1	f386c64a-00c3-0266-e053-dadaa90a7c1a	VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP Extended Release Film Coated Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-5253-4	VERAPAMIL HYDROCHLORIDE	30 in 1 BOTTLE	TABLET	30		9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-5253-4	EA - Each	50090-5253	cb99a72d-a7f3-437d-95f2-3543f2a752e3	1	2023-07-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-5253	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS]	9	Current NDC, Legacy NDC, 1 package rows	20230613_5467dad4-f3ba-4036-b5f4-4d2d4d5abc34.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 17 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Nivagen Pharmaceuticals, Inc.	e36e485f-fbed-4e30-9a63-984931f2e54e	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Bryant Ranch Prepack	1de6ad5c-942e-4381-b01f-e5e63bbf72ef	2026-03-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Cadila Pharmaceuticals Limited	5501208c-aa2b-47aa-89f7-87f4d4a73fd0	2026-02-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Northwind Health Company, LLC	db990ce1-b193-4a81-e053-2a95a90a627b	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Northwind Health Company, LLC	e08c07bf-58b4-6fa2-e053-2a95a90aca32	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	REMEDYREPACK INC.	d7c29dfd-3968-41ac-a081-e670f9bd605c	2025-11-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Preferred Pharmaceuticals Inc.	b0eeada4-1010-4c11-b408-29f9a1af23c0	2025-10-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	fe05b8d8-fdee-903b-e053-6394a90a2e05	2025-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	fdb7cd57-d33c-f5a3-e053-6294a90aff31	2024-12-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	A-S Medication Solutions	0b00ec93-0bb3-4181-a6ef-45206f0621f7	2024-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	a58f5f77-7e88-d622-e053-2a95a90a0d35	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Bryant Ranch Prepack	f88dfe56-08bc-46b1-8f05-f886a16a89bc	2024-07-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Bryant Ranch Prepack	2f839b5c-b8e7-40df-887f-7df94326fc7b	2023-12-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	A-S Medication Solutions	ed182ebe-8299-4680-9dea-ef79d30db683	2023-11-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	A-S Medication Solutions	5467dad4-f3ba-4036-b5f4-4d2d4d5abc34	2023-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173 ndc (product): 50090-5253
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Proficient Rx LP	343724eb-e80b-4729-80e7-6b8028713ea1	2023-05-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	2712ab16-122b-4f44-a687-e2cb3c04019e	2020-04-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206173 application number: ANDA206173

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V3888OEY5R	VERAPAMIL HYDROCHLORIDE	152-11-4	VERAPAMIL HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
897640	verapamil HCl 180 MG Extended Release Oral Tablet	PSN	5467dad4-f3ba-4036-b5f4-4d2d4d5abc34	9
897640	verapamil hydrochloride 180 MG Extended Release Oral Tablet	SCD	5467dad4-f3ba-4036-b5f4-4d2d4d5abc34	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-5253-4	50090525304	30 TABLET in 1 BOTTLE (50090-5253-4)	30 tablet	2020-10-14	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
VERAPAMIL HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP Extended Release Film Coated Tablets	A-S Medication Solutions	2023-06-12	Human Prescription Drug Label	9